z-logo
open-access-imgOpen Access
Posaconazole Combined with Amphotericin B, an Effective Therapy for a Murine Disseminated Infection Caused by Rhizopus oryzae
Author(s) -
M. Mar Rodríguez,
Carolina Serena,
Marçal Mariné,
F. Javier Pastor,
Josep Guarro
Publication year - 2008
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00628-08
Subject(s) - posaconazole , amphotericin b , rhizopus oryzae , zygomycosis , medicine , rhizopus , body weight , mucormycosis , pharmacology , mycosis , combination therapy , antifungal , immunology , biology , surgery , dermatology , food science , fermentation
In a murine model of disseminated zygomycosis, low doses of amphotericin B (0.3 mg/kg body weight/day) combined with posaconazole (40 mg/kg/day) prolonged survival and reduced tissue burden with respect to that of controls and that of both drugs administered alone. Results were similar to those obtained with amphotericin B given alone at 0.8 mg/kg/day.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom